{"id":"NCT02481830","sponsor":"Bristol-Myers Squibb","briefTitle":"Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer","officialTitle":"An Open-label, Randomized, Phase 3 Study of Nivolumab or Chemotherapy in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First Line Chemotherapy (CheckMate 331: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 331)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-14","primaryCompletion":"2018-08-17","completion":"2022-08-30","firstPosted":"2015-06-25","resultsPosted":"2020-01-09","lastUpdate":"2023-07-27"},"enrollment":569,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lung Cancer"],"interventions":[{"type":"DRUG","name":"Nivolumab","otherNames":[]},{"type":"DRUG","name":"Topotecan","otherNames":[]},{"type":"DRUG","name":"Amrubicin","otherNames":[]}],"arms":[{"label":"Arm A Nivolumab","type":"EXPERIMENTAL"},{"label":"Arm B Chemotherapy Topotecan","type":"ACTIVE_COMPARATOR"},{"label":"Arm B Chemotherapy Amrubicin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the overall survival of nivolumab versus chemotherapy in subjects with relapsed SCLC.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"OS was followed continuously while participants were on the study drug and every 3 months, minimum follow up for overall survival was 15.8 months","effectByArm":[{"arm":"Group A","deltaMin":7.46,"sd":null},{"arm":"Group B","deltaMin":8.38,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1144"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":151,"countries":["United States","Australia","Austria","Belgium","Brazil","Chile","China","Czechia","Denmark","France","Germany","Greece","Hungary","Israel","Italy","Japan","Norway","Poland","Romania","Russia","South Korea","Spain","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSStudyConnect.com"]},"adverseEventsSummary":{"seriousAny":{"events":183,"n":282},"commonTop":["Anaemia","Decreased appetite","Fatigue","Asthenia","Cough"]}}